PreveCeutical Medical Inc (18H) — Capital Reinvestment Ratio

Latest as of September 2020: 0.04x

PreveCeutical Medical Inc (18H) has a Capital Reinvestment Ratio of 0.04x as of September 2020, meaning it reinvests 0% of its operating cash flow (€520.22K) in capital expenditures (€21.18K). See PreveCeutical Medical Inc net asset quality index to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.04x
Capex / Operating Cash Flow

Operating Cash Flow

€520.22K
EUR

Capital Expenditures

€21.18K
EUR

Data as of

Sep 2020
Most recent filing

PreveCeutical Medical Inc Capital Reinvestment Ratio (2020–2020)

This chart tracks PreveCeutical Medical Inc's Capital Reinvestment Ratio across 1 annual periods. Check 18H cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for PreveCeutical Medical Inc (2020–2020)

Year-by-year Capital Reinvestment Ratio for PreveCeutical Medical Inc from 2020 to 2020. For live market cap and broader valuation context, see 18H company net worth.

Year Reinvestment Ratio Operating CF (EUR) Capital Expenditures YoY Change
2020 0.04x €64.59K €2.65K —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow